Insulin Sensitivity Factor for Steroid-Induced Hyperglycemia
For a patient on prednisone 40 mg daily (20 mg BID) with NPH insulin 50 U AM and 24 U PM, start with an insulin sensitivity factor (ISF) of 1:30 to 1:40 (1 unit of insulin lowers blood glucose by 30-40 mg/dL), recognizing that steroid-induced insulin resistance will require significantly more aggressive correction than typical calculations suggest.
Understanding the Clinical Context
This patient presents a complex scenario of steroid-induced hyperglycemia, which fundamentally alters insulin sensitivity. The prednisone 40 mg daily dose creates substantial insulin resistance, particularly affecting afternoon and evening glucose levels 1.
Key Physiological Considerations
Prednisone's impact on insulin requirements:
- Insulin resistance increases by approximately 64-70% during glucocorticoid therapy 2, 3
- The current total daily insulin dose of 74 units (50 AM + 24 PM NPH) may already reflect this increased requirement
- Maximal hyperglycemic effect occurs between midday and midnight, corresponding to prednisone's pharmacodynamics 4
Calculating the Insulin Sensitivity Factor
Standard Calculation Method
The traditional "1800 rule" or "1500 rule" provides a starting framework 5:
Using the 1800 rule:
- ISF = 1800 ÷ Total Daily Insulin Dose
- ISF = 1800 ÷ 74 units = approximately 1:24
However, this calculation requires critical adjustment for steroid use.
Adjusted ISF for Steroid-Induced Hyperglycemia
The evidence strongly suggests more conservative (higher) ISF values are needed:
Initial ISF recommendation: 1:30 to 1:40
Time-of-day considerations:
- Morning/midday ISF: 1:30 (more aggressive, as steroid effect peaks)
- Evening/bedtime ISF: 1:40 (more conservative, as steroid effect diminishes and NPH peaks overnight)
Critical Management Principles
NPH Timing Optimization
The current twice-daily NPH regimen is appropriate for steroid-induced hyperglycemia 1. The 2025 ADA guidelines specifically recommend morning NPH dosing for steroid-induced hyperglycemia, and this patient's 50 U AM dose aligns with this recommendation.
Monitoring and Titration Strategy
Adjust ISF based on pattern analysis:
- If correction doses consistently fail to bring glucose to target → decrease ISF (e.g., from 1:40 to 1:30)
- If hypoglycemia occurs after corrections → increase ISF (e.g., from 1:30 to 1:50)
- Reassess every 2-3 days as steroid dose or insulin requirements change 1
Common Pitfalls to Avoid
Using standard ISF calculations without steroid adjustment - This leads to overcorrection and hypoglycemia risk, particularly at night when steroid effect wanes while NPH peaks 4
Applying the same ISF throughout the day - Steroid-induced hyperglycemia has distinct diurnal patterns requiring time-specific ISF values 6, 7
Failing to reduce ISF when prednisone is tapered - Insulin sensitivity rapidly improves when steroids are discontinued; ISF should be recalculated within 24-48 hours of dose reduction 2
Practical Implementation Algorithm
Step 1: Start with ISF 1:30 for daytime corrections (0600-1800)
Step 2: Use ISF 1:40 for evening/bedtime corrections (1800-0600)
Step 3: Monitor pre-meal and bedtime glucose for 2-3 days
Step 4: Adjust based on patterns:
- If >50% of post-correction values remain >180 mg/dL → decrease ISF by 10 points
- If any glucose <70 mg/dL after correction → increase ISF by 10 points
Step 5: When prednisone dose changes, recalculate ISF using the 1800 rule with new total daily insulin dose, then apply steroid adjustment factor
Carbohydrate Coverage Consideration
With 220 g carbohydrate daily distributed across meals, the insulin-to-carbohydrate ratio (ICR) also requires attention. Using the "500 rule":
- ICR = 500 ÷ 74 = approximately 1:7 (1 unit per 7 g carbohydrate)
- This should be adjusted similarly to ISF, potentially to 1:5 or 1:6 during peak steroid effect 5
Evidence Strength and Nuances
The 2025 ADA guidelines 1 provide the framework for NPH-based regimens but do not specify ISF calculations for steroid-induced hyperglycemia. Research evidence 2, 4, 6 demonstrates that insulin requirements increase 30-70% with glucocorticoids, supporting more conservative ISF values than standard calculations suggest.
The most robust evidence comes from the 2018 randomized trial 6 showing NPH-based protocols improve glycemic control in hospitalized patients on corticosteroids, and the 2017 study 4 demonstrating that standard basal-bolus regimens may undertreat daytime hyperglycemia while causing nocturnal hypoglycemia.